UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
BROWN, MARVIN R.
10350 North Torrey Pines Road
La Jolla, CA 92037
USA
2. Issuer Name and Ticker or Trading Symbol
AGOURON PHARMACEUTICALS, INC.
(AGPH)
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
06/30/97
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
( ) Director ( ) 10% Owner (X) Officer (give title below) (X) Other
(specify below)
See Explanation of Responses (*.)
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Month |ect(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C><C> <C> <C> <C> <C> <C>
Common Stock |06/11/|M | |5,000 |A |$0.53 | | | |
|97 | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |06/11/|S | |5,000 |D |$82.50 | | | |
|97 | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |06/11/|M | |1,250 |A |$0.53 |100,138 |D | |
|97 | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |06/30/|M | |1,883 |A |$0.53 | | | |
|97 | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |06/30/|M | |188 |A |$7.96 |2,071 |I |By Wife |
|97 | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Month |(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C><C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option |$0.53 |06/11|M | |5,000 |D |** |01/18|Common Stock|5,000 | | | | |
(Right to Buy) | |/97 | | | | | |/06 | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Employee Stock Option |$0.53 |06/11|M | |1,250 |D |** |01/18|Common Stock|1,250 | |12,585 |D | |
(Right to Buy) | |/97 | | | | | |/06 | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Employee Stock Option |$0.53 |06/30|M | |1,883 |D |*** |06/26|Common Stock|1,883 | | | | |
(Right to Buy) | |/97 | | | | | |/04 | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Employee Stock Option |$7.96 |06/30|M | |188 |D |**** |12/31|Common Stock|188 | |-0- |I |By Wife |
(Right to Buy) | |/97 | | | | | |/06 | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
* Officer: Vice President of Agouron Pharmaceuticals,
Inc.
Other: President of Alanex Corporation, a wholly-owned subsidiary of Agouron
Pharmaceuticals, Inc.
** This option vested over 3 years with approximately 2.78% vesting per month
until fully vested.
*** This option vested over 4 years with approximately 2.07% vesting per month
until fully vested.
****This option vested over 4 years with approximately 2% vesting per month
until fully vested.
SIGNATURE OF REPORTING PERSON
/s/ Marvin R. Brown
DATE
07/09/97
